Francisco Fuster

Vina Del Mar, VS, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

High hepatitis B exposure and HIV prevalence but no evidence of HDV among Haitian migrants in Chile: A cross-sectional study.

High hepatitis B exposure and HIV prevalence but no evidence of HDV among Haitian migrants in Chile: A cross-sectional study.

Journal: Journal of infection and public health

Published: August 03, 2025

Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.

Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.

Journal: Journal of viral hepatitis

Published: July 18, 2022

Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.

Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.

Journal: JAMA network open

Published: August 23, 2021

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial.

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial.

Journal: Nature medicine

Published: September 01, 2020

Infectious and non-infectious diseases burden among Haitian immigrants in Chile: a cross-sectional study.

Infectious and non-infectious diseases burden among Haitian immigrants in Chile: a cross-sectional study.

Journal: Scientific reports

Published: May 22, 2020

Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.

Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 01, 2019

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.

Journal: The New England journal of medicine

Published: January 25, 2018

Direct antivirals for the treatment of chronic hepatitis C virus infection. Experience in 106 patients

Direct antivirals for the treatment of chronic hepatitis C virus infection. Experience in 106 patients

Journal: Revista medica de Chile

Published: January 02, 2017

Achieving protection against HBV in HIV patients: Finding the best strategy.

Achieving protection against HBV in HIV patients: Finding the best strategy.

Journal: Human vaccines & immunotherapeutics

Published: September 27, 2016

CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.

CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.

Journal: Vaccine

Published: December 03, 2015

Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.

Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.

Journal: Journal of medical virology

Published: September 15, 2015

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.

Journal: Journal of hepatology

Published: April 15, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026